A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain. - Wikidata - wikimedia - TriplyDB

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.

http://www.wikidata.org/entity/Q34805216

about

Opioid-induced constipation: advances and clinical guidance Recent Updates on the Treatment of Constipation The role of naloxegol in the management of opioid-induced bowel dysfunction Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities Persistent constipation and abdominal adverse events with newer treatments for constipation.Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.Advances in pharmacotherapy for opioid-induced constipation - a systematic review.Lubiprostone in constipation: clinical evidence and place in therapy.Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.Narcotic bowel syndrome and opioid-induced constipation.Management of opioid-induced constipation for people in palliative care.Chronic Constipation: a Review of Current Literature.New Options in Constipation Management.Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders.Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature.Opioids and GI Motility-Friend or Foe?Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain.Treatment With Naloxegol Versus Placebo: Pain Assessment in Patients With Noncancer Pain and Opioid-Induced Constipation.Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.Opioid-induced constipation.New developments in the treatment of opioid-induced gastrointestinal symptoms Clinical utility of plecanatide in the treatment of chronic idiopathic constipation

P2860

Q26765571-5A8EC99B-F2B7-4715-9B4D-D985174D1C59 Q26820242-C56CF8C1-A481-4A8A-8B25-F107D64F7796 Q28072039-9D1B6F88-459E-45A6-9F9C-4E2BBDB19825 Q28083547-520A6ECB-1355-4971-9AE6-390CDEE14A0E Q33468562-11C6E205-70CD-4BAB-A67F-793853B66EF1 Q33854983-CA527BCB-A51B-48E1-A9B6-EBB1BFD8C43B Q34455604-EF317563-E62F-4325-ABBF-1964EE01166F Q35091370-AFE28B45-D117-4744-A321-6D1ADF2EB240 Q37233788-B80654A3-AA45-4CC0-8A92-1C9A44FD4308 Q37603682-63E04D87-7A8D-46A2-8A13-436693C8CB51 Q38245693-611F44B3-A61D-490B-B372-FF327EAF5459 Q38540868-20CFA658-3E15-4BD8-A638-9058992337D9 Q38602661-945BD2B7-1B57-49E4-9120-C74C494E07B7 Q38602701-943DCDCC-1A53-4841-AF25-931574C9B9E4 Q38604426-3D2C97A8-FF89-478E-A314-1A354249C890 Q38761898-B63D64A3-09C7-4B00-8209-8CEE93B5F66E Q38772298-7BCFB80F-5FA8-47BC-A559-AB281AE3C0D3 Q38880480-A4BBABA3-00F5-47EF-B61C-932E2C71B1E8 Q38997203-4D23F81A-1413-43BD-9A3F-9E3F1CCA8018 Q39051851-7E38E7D2-A402-46CB-AEFA-D054EDF1054E Q39175158-00798D9A-8DCD-448B-B5CB-C88650C0365B Q43062741-0CC5375A-6CED-412E-A7B8-6742E4C2617E Q43075638-E731243B-E0BD-4C33-B21C-4846916EC825 Q44331744-D1E05B3D-1C59-4ED2-AA4B-EB80FF472589 Q44348840-B18F6E64-FC54-4C45-8BDF-FD1238A8FBFD Q44349621-4CBB5F99-60A0-42E8-A14A-D7FF43D93BAE Q50062006-94497BAD-8ACC-4249-A842-FEBBA29B0803 Q54262333-2C89B3F7-4BBA-40D9-A381-797276FB03B8 Q57063309-FCFAAF28-3020-4C77-970E-5BE77CBE4075 Q58790572-95FABC38-E500-46CA-A6FE-5CD405BC2548

P2860

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.

http://www.wikidata.org/entity/Q34805216

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A randomized study of lubipros ...... s with chronic noncancer pain.

@ast

A randomized study of lubipros ...... s with chronic noncancer pain.

@en

A randomized study of lubipros ...... s with chronic noncancer pain.

@nl

type

label

A randomized study of lubipros ...... s with chronic noncancer pain.

@ast

A randomized study of lubipros ...... s with chronic noncancer pain.

@en

A randomized study of lubipros ...... s with chronic noncancer pain.

@nl

prefLabel

A randomized study of lubipros ...... s with chronic noncancer pain.

@ast

A randomized study of lubipros ...... s with chronic noncancer pain.

@en

A randomized study of lubipros ...... s with chronic noncancer pain.

@nl

P1433

Q34805216-1E471455-1E02-4D7F-847E-633CBDE2B3A2

P1476

Q34805216-55BE632B-47D8-4C0E-87BD-451440C8C1A9

P2093

Q34805216-2B005967-F983-47E8-B56C-F0C61544B930

Q34805216-6ADFE72B-45FD-4416-9812-21818C4BDD02

Q34805216-8B23A77A-9A7F-43A3-AA4C-2942B9A0500B

Q34805216-ED418874-0B87-4C0B-8A59-887A85D8530D

P2860

Q34805216-0DAAE2AA-D2F6-41F7-AA48-024B8759B091

Q34805216-11BFDF2B-C3D4-41B7-A9FA-D6D773930F70

Q34805216-12DBE5F8-00A5-48DE-A32C-66B29DEA90AC

Q34805216-139909DF-0608-48B0-9026-2E578D5E3F26

Q34805216-37200303-652D-4AC0-B016-C8914929B289

Q34805216-386F1BF7-C5D9-48F1-A83B-C63EEB0865C3

Q34805216-3FD7E65A-4377-4C9B-9402-2C5CCAF4FDE2

Q34805216-425D7ED8-A58B-4A35-A43B-04DF7B49BAD7

Q34805216-50F7E610-E0C9-43FF-BEE9-7A99D3D1C914

Q34805216-52FEADF5-75BA-421F-80BE-6FF686602DC3

P304

Q34805216-84CD1494-4A7C-4859-B755-CD1AEDB10010

P31

Q34805216-E902E34F-D512-4CDF-A612-F09E75696C0E

P356

Q34805216-E3AE5CBF-676A-4684-85F3-A9C282ACBF68

P433

Q34805216-8B5FE14F-8199-4C42-903F-09C0A2D30EC7

P478

Q34805216-EBA69931-CFE7-4DED-A3FB-19CA491078A8

P50

Q34805216-D5C63267-A9FA-41B4-BE4A-8308130ACCB2

P577

Q34805216-EC65FCB2-7D99-4767-83AE-0C2C9E9F6A23

P5875

Q34805216-AA5EA72C-1540-40BC-AD15-241013C0D14A

P698

Q34805216-16443CB2-D810-4D46-A814-B01E2036FC00

P921

Q34805216-52A925CE-E146-4F59-938A-BEC41E15E281

Q34805216-6c7f9597-0fad-4aa3-b149-4c1e3439ec06

Q34805216-C37C4A44-DBEB-4ACA-92D0-04C4AD1C5CF3

P932

Q34805216-920FB71C-FAF2-43AB-A898-0D72CD1C0128

P356

P1433

P1476

A randomized study of lubipros ...... s with chronic noncancer pain.

@en

P2093

Anca Popescu

http://www.w3.org/2001/XMLSchema#string

Byron Cryer

http://www.w3.org/2001/XMLSchema#string

Ricardo Vallejo

http://www.w3.org/2001/XMLSchema#string

Ryuji Ueno

http://www.w3.org/2001/XMLSchema#string

P2860

Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.

Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse.

Efficacy and safety of lubiprostone in patients with chronic constipation.

The prevalence of chronic pain in United States adults: results of an Internet-based survey.

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Opioid receptors in the gastrointestinal tract.

The role of opioids in cancer pain.

Lubiprostone: a chloride channel activator.

P304

1825-1834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PME.12437

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261477165

http://www.w3.org/2001/XMLSchema#string

P698

24716835

http://www.w3.org/2001/XMLSchema#string

P921

P932

4282321

http://www.w3.org/2001/XMLSchema#string